AbbVie
ABBV
#25
Rank
ยฃ297.36 B
Marketcap
ยฃ168.25
Share price
0.98%
Change (1 day)
25.78%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Cash on Hand

Cash on Hand as of September 2025 : ยฃ4.23 Billion

According to AbbVie's latest financial reports the company has ยฃ4.23 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

AbbVie - Cash on Hand chart (from 2011 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ4.42 B-56%
2023-12-31ยฃ10.05 B31.87%
2022-12-31ยฃ7.62 B4.75%
2021-12-31ยฃ7.28 B17.07%
2020-12-31ยฃ6.22 B-79.57%
2019-12-31ยฃ30.44 B379.43%
2018-12-31ยฃ6.35 B-12.32%
2017-12-31ยฃ7.24 B39.14%
2016-12-31ยฃ5.20 B-8.24%
2015-12-31ยฃ5.67 B5.47%
2014-12-31ยฃ5.37 B-10.34%
2013-12-31ยฃ5.99 B21.56%
2012-12-31ยฃ4.93 B1074.59%
2011-12-31ยฃ0.42 B5919.07%
2010-12-31ยฃ6.97 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
ยฃ11.19 B 164.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ12.33 B 190.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ7.40 B 74.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ7.05 B 66.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ5.49 B 29.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ2.95 B-30.16%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ3.32 B-21.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
ยฃ6.11 B 44.28%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
ยฃ0.83 B-80.34%๐Ÿ‡บ๐Ÿ‡ธ USA